Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
- PMID: 2676191
- DOI: 10.1016/0092-8674(89)90873-8
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
Abstract
The unprocessed Gag precursor from HIV-1, when expressed in recombinant baculovirus-infected insect cells, is targeted to the plasma membrane and assembles in 100-120 nm particles budding from the cell surface. This process mimics HIV immature particle formation and is dependent on myristoylation of the N-terminal glycine, as deletion of the latter results in particle accumulation in the cytoplasm and, interestingly, in the nucleus, pointing to a potential role of this non-fatty-acid-acylated species in the viral life cycle. Inclusion of the pol gene in the construct results in efficient processing of Pr55gag and a pronounced decrease in particle formation. Deletion of the C terminus (p16) of the Gag precursor, including the finger domains, abolishes particle assembly, but membrane targeting and evagination still occur. Heterologous expression in insect cells may prove very useful for the study of the molecular events leading to retroviral particle morphogenesis.
Similar articles
-
Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.Arch Virol. 1992;127(1-4):117-37. doi: 10.1007/BF01309579. Arch Virol. 1992. PMID: 1456888
-
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994. J Virol. 1994. PMID: 8254720 Free PMC article.
-
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles.EMBO J. 1989 Sep;8(9):2653-60. doi: 10.1002/j.1460-2075.1989.tb08405.x. EMBO J. 1989. PMID: 2684654 Free PMC article.
-
Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.J Gen Virol. 2001 Nov;82(Pt 11):2719-2733. doi: 10.1099/0022-1317-82-11-2719. J Gen Virol. 2001. PMID: 11602784
-
Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.J Gen Virol. 1998 May;79 ( Pt 5):1069-81. doi: 10.1099/0022-1317-79-5-1069. J Gen Virol. 1998. PMID: 9603321
Cited by
-
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.J Virol. 1991 Jun;65(6):3203-12. doi: 10.1128/JVI.65.6.3203-3212.1991. J Virol. 1991. PMID: 2033671 Free PMC article.
-
N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation.J Virol. 1990 Aug;64(8):3995-4001. doi: 10.1128/JVI.64.8.3995-4001.1990. J Virol. 1990. PMID: 2164607 Free PMC article.
-
A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration.Membranes (Basel). 2022 Dec 9;12(12):1248. doi: 10.3390/membranes12121248. Membranes (Basel). 2022. PMID: 36557156 Free PMC article.
-
Virus-like particles: models for assembly studies and foreign epitope carriers.Prog Nucleic Acid Res Mol Biol. 2005;80:135-68. doi: 10.1016/S0079-6603(05)80004-2. Prog Nucleic Acid Res Mol Biol. 2005. PMID: 16164974 Free PMC article. Review.
-
RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.J Virol. 2011 Jan;85(1):305-14. doi: 10.1128/JVI.02626-09. Epub 2010 Oct 27. J Virol. 2011. PMID: 20980522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources